Deadline: 1-Sep-22
The Nordic Cancer Union (NCU) is offering grants through its Research Grant Program to provide funding to support and stimulate collaborative cancer research within the Nordic countries.
The applying researcher’s and collaborators involved in the project must be working in at least three, and preferably several different Nordic countries. The research project must be cancer relevant and uniquely suited to be carried out within the Nordic countries, and the effect of collaboration should be synergistic.
Priorities
- Register-based epidemiological studies: There is a unique possibility for register-based epidemiological studies in the Nordic countries, and the NCU will continue to encourage more research in this field. The use of nationwide administrative and health registers and various population-based clinical databases facilitates cancer research initiatives within all prioritized research areas. These data sources may soon be combined with data from national biobanks, which will enhance the precision and biological relevance of the research.
- Descriptive epidemiology: The NCU will continue to encourage intensified research within descriptive epidemiology. Research on trends in incidence, mortality and survival of cancer in the Nordic countries should be encouraged in order to identify fields in cancer prevention or management in which improvement is needed. Cross-country comparisons are imperative in 2 assessing current national strategic cancer programs and health care policies, and how they should be prioritized.
- Clinical trials: Finally, there should be focus on clinical trials. The number of clinical trials has decreased considerably in the Nordic countries in recent years. A large number of clinical trials are conducted in lower-cost countries and in larger patient populations than in the individual Nordic countries. Non-economic factors relating to, e.g., organizational aspects or Nordic participation in international networks of oncology, may also contribute to the decrease in clinical trial activity. Clinical trials require large patient groups, which may be difficult to achieve in the individual Nordic countries. By placing focus on clinical trials they wish to encourage more cooperation between the Nordic countries.
Funding Information
NCU research grants are provided for one year. Further support for the project will require a new, yearly application. Project funding can only be renewed twice; a project can obtain funding from the NCU for a total of maximum of three years.
Terms and Conditions
- The NCU Research Grant can only be used for the purposes stated in the application. If the funds have not been used as specified in the application, repayment is required
- The NCU Administration must approve any project changes that deviate from the original application
- Leaves of absence are not considered project deviations but must be approved by the NCU Administration. The NCU does not compensate for any additional costs due to leaves of absence
- A yearly progress report must be submitted until the project is completed. Upon project completion, a final report must be submitted
- The principal investigator is obligated to mention the NCU’s contribution to the project in all external communication related to the project, including lectures, posters, and publications
- It is the grant holder’s responsibility to obtain permissions/approvals from, e.g. the Data Protection Agency, Ethics Committee and Animal Research Authority before the start-up of the project
- Grants are awarded under the provision that the grantee has not received, does not receive, or does not expect to receive support for the project from companies/groups/foundations whose production or turnover to a large extent includes current income from production and sale of obvious carcinogens, in particular tobacco.
For more information, visit Nordic Cancer Union.
For more information, visit https://ncu.nu/cancer-research/application/